We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

90 hedge funds and large institutions have $20.4M invested in Zomedica Corp. in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

7% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 15

1% less funds holding

Funds holding: 91 → 90 (-1)

13% less capital invested

Capital invested by funds: $23.5M → $20.4M (-$3.07M)

Holders
90
Holders Change
-1
Holders Change %
-1.1%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
16
Reduced
15
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ProShare Advisors
ProShare Advisors
Maryland
+$522K
2
Jane Street
Jane Street
New York
+$166K
3
Charles Schwab
Charles Schwab
California
+$101K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$94.7K
5
BCI
Brinker Capital Investments
Pennsylvania
+$87.6K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$258K
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$52.3K
3
Morgan Stanley
Morgan Stanley
New York
-$47.9K
4
MCC
Money Concepts Capital
Florida
-$24.8K
5
Renaissance Technologies
Renaissance Technologies
New York
-$21K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$10.4M +$41K +167,305 +0.3%
Cambridge Investment Research Advisors
2
Cambridge Investment Research Advisors
Iowa
$2.38M +$15.8K +64,400 +0.6%
BlackRock
3
BlackRock
New York
$2.17M -$258K -1,052,849 -9%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$1.97M +$94.7K +386,149 +4%
State Street
5
State Street
Massachusetts
$703K -$4.09K -16,700 -0.5%
BBHC
6
Brown Brothers Harriman & Co
New York
$484K – – –
ProShare Advisors
7
ProShare Advisors
Maryland
$451K +$522K +2,130,738 New
Northern Trust
8
Northern Trust
Illinois
$375K +$22.4K +91,406 +5%
PWMG
9
Pinnacle Wealth Management Group
Michigan
$206K – – –
Jane Street
10
Jane Street
New York
$201K +$166K +678,282 +251%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$123K – – –
Charles Schwab
12
Charles Schwab
California
$87.3K +$101K +412,334 New
BCI
13
Brinker Capital Investments
Pennsylvania
$75.6K +$87.6K +357,151 New
OPS
14
Orion Portfolio Solutions
Nebraska
$75.6K +$87.6K +357,151 New
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$71K – – –
Qube Research & Technologies (QRT)
16
Qube Research & Technologies (QRT)
United Kingdom
$65K +$29.3K +119,591 +64%
GT
17
Glenmede Trust
Pennsylvania
$51.4K – – –
Morgan Stanley
18
Morgan Stanley
New York
$50.9K -$47.9K -195,312 -45%
SCA
19
Snowden Capital Advisors
New York
$50.4K – – –
VF
20
Virtu Financial
New York
$42K +$44.5K +181,548 +1,047%
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$34K +$23K +93,804 +146%
Victory Capital Management
22
Victory Capital Management
Texas
$23K -$71 -289 -0.3%
Cerity Partners
23
Cerity Partners
New York
$21.2K – – –
EDRH
24
Edmond de Rothschild Holding
Switzerland
$21.2K – – –
WMA
25
West Michigan Advisors
Michigan
$21.2K – – –
1
2 3 4

ZOM Hedge Fund Activity: Q1 2023 in Review

90 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2023, worth a combined $20.4M — down 13% from $23.5M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ZOM positions and 11 closed out — a net gain of 3 holders — while 16 added to existing stakes and 15 trimmed.

The largest buyer was ProShare Advisors, opening a new position worth an estimated $522K. The largest seller was BlackRock, cutting an estimated $258K.

  • 90 institutional investors held Zomedica Corp. (ZOM) as of Q1 2023, down from 91 in Q4 2022.
  • Funds reported $20.4M of Zomedica Corp. stock for Q1 2023, down 13% quarter-over-quarter.
  • 14 funds opened new Zomedica Corp. positions in Q1 2023 and 11 closed out, a net change of +3 holders.
  • The largest Zomedica Corp. buyer in Q1 2023 was ProShare Advisors, an estimated $522K added.
  • The largest Zomedica Corp. seller in Q1 2023 was BlackRock, an estimated $258K sold.

Based on aggregated 13F filings for Q1 2023.